Purdue Pharma Bankruptcy Mediator Says Sacklers, US States Closer to Deal Over Opioid Claims

Purdue Pharma Bankruptcy Mediator Says Sacklers, US States Closer to Deal Over Opioid Claims
A pharmacist holds prescription painkiller OxyContin, 40mg pills, made by Purdue Pharma L.D. at a local pharmacy, in Provo, Utah, on April 25, 2017. George Frey/Reuters
|Updated:

A mediator reported on Tuesday that members of the Sackler family that own Purdue Pharma and U.S. states opposed to the OxyContin-maker’s bankruptcy exit plan are “even closer” to a settlement over claims that the company fueled a U.S. opioid epidemic.

The mediator asked a bankruptcy judge to extend the deadline for negotiations to Feb. 16 from Feb. 7, saying that the two sides need more time to finalize a deal that would involve “substantial” additional money from the Sacklers, according to court documents filed on Tuesday. The new settlement would also include non-monetary concessions.